King Pharmaceuticals Inc Stock Market Value
| KG Stock | 23.71 0.79 3.45% |
| Symbol | KING |
KING PHARMACEUTICALS INC Company Valuation
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of KING PHARMACEUTICALS. If investors know KING will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about KING PHARMACEUTICALS listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share 0.03 |
The market value of KING PHARMACEUTICALS INC is measured differently than its book value, which is the value of KING that is recorded on the company's balance sheet. Investors also form their own opinion of KING PHARMACEUTICALS's value that differs from its market value or its book value, called intrinsic value, which is KING PHARMACEUTICALS's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because KING PHARMACEUTICALS's market value can be influenced by many factors that don't directly affect KING PHARMACEUTICALS's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between KING PHARMACEUTICALS's value and its price as these two are different measures arrived at by different means. Investors typically determine if KING PHARMACEUTICALS is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, KING PHARMACEUTICALS's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
KING PHARMACEUTICALS 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to KING PHARMACEUTICALS's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of KING PHARMACEUTICALS.
| 04/22/2025 |
| 07/21/2025 |
If you would invest 0.00 in KING PHARMACEUTICALS on April 22, 2025 and sell it all today you would earn a total of 0.00 from holding KING PHARMACEUTICALS INC or generate 0.0% return on investment in KING PHARMACEUTICALS over 90 days. KING PHARMACEUTICALS is related to or competes with Pinterest, Brandywine Realty, Primo Brands, NETGEAR, and Radcom. KING PHARMACEUTICALS is entity of United States More
KING PHARMACEUTICALS Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure KING PHARMACEUTICALS's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess KING PHARMACEUTICALS INC upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 6.17 | |||
| Information Ratio | 0.0459 | |||
| Maximum Drawdown | 63.96 | |||
| Value At Risk | (8.88) | |||
| Potential Upside | 15.0 |
KING PHARMACEUTICALS Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for KING PHARMACEUTICALS's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as KING PHARMACEUTICALS's standard deviation. In reality, there are many statistical measures that can use KING PHARMACEUTICALS historical prices to predict the future KING PHARMACEUTICALS's volatility.| Risk Adjusted Performance | 0.0672 | |||
| Jensen Alpha | 0.3395 | |||
| Total Risk Alpha | (0.67) | |||
| Sortino Ratio | 0.0632 | |||
| Treynor Ratio | 0.3762 |
KING PHARMACEUTICALS INC Backtested Returns
KING PHARMACEUTICALS appears to be somewhat reliable, given 3 months investment horizon. KING PHARMACEUTICALS INC has Sharpe Ratio of 0.0501, which conveys that the firm had a 0.0501 % return per unit of volatility over the last 3 months. We have found twenty-eight technical indicators for KING PHARMACEUTICALS, which you can use to evaluate the volatility of the firm. Please exercise KING PHARMACEUTICALS's risk adjusted performance of 0.0672, and Mean Deviation of 5.44 to check out if our risk estimates are consistent with your expectations. On a scale of 0 to 100, KING PHARMACEUTICALS holds a performance score of 3. The company secures a Beta (Market Risk) of 1.38, which conveys a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, KING PHARMACEUTICALS will likely underperform. Please check KING PHARMACEUTICALS's downside variance, and the relationship between the treynor ratio and kurtosis , to make a quick decision on whether KING PHARMACEUTICALS's current price movements will revert.
Auto-correlation | -0.31 |
Poor reverse predictability
KING PHARMACEUTICALS INC has poor reverse predictability. Overlapping area represents the amount of predictability between KING PHARMACEUTICALS time series from 22nd of April 2025 to 6th of June 2025 and 6th of June 2025 to 21st of July 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of KING PHARMACEUTICALS INC price movement. The serial correlation of -0.31 indicates that nearly 31.0% of current KING PHARMACEUTICALS price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.31 | |
| Spearman Rank Test | -0.07 | |
| Residual Average | 0.0 | |
| Price Variance | 2.27 |
KING PHARMACEUTICALS INC lagged returns against current returns
Autocorrelation, which is KING PHARMACEUTICALS stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting KING PHARMACEUTICALS's stock expected returns. We can calculate the autocorrelation of KING PHARMACEUTICALS returns to help us make a trade decision. For example, suppose you find that KING PHARMACEUTICALS has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
KING PHARMACEUTICALS regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If KING PHARMACEUTICALS stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if KING PHARMACEUTICALS stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in KING PHARMACEUTICALS stock over time.
Current vs Lagged Prices |
| Timeline |
KING PHARMACEUTICALS Lagged Returns
When evaluating KING PHARMACEUTICALS's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of KING PHARMACEUTICALS stock have on its future price. KING PHARMACEUTICALS autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, KING PHARMACEUTICALS autocorrelation shows the relationship between KING PHARMACEUTICALS stock current value and its past values and can show if there is a momentum factor associated with investing in KING PHARMACEUTICALS INC.
Regressed Prices |
| Timeline |
Currently Active Assets on Macroaxis
Check out KING PHARMACEUTICALS Correlation, KING PHARMACEUTICALS Volatility and KING PHARMACEUTICALS Alpha and Beta module to complement your research on KING PHARMACEUTICALS. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
KING PHARMACEUTICALS technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.